Mai M. Abouzeid, Mohamed Ghonim, Hamid Boulares. "Turning clinically approved PARP inhibitors into immunotherapy sensitizers by reprogramming the tumor microenvironment in colorectal cancer.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.e14552